통합검색
내가 찾은 검색어
'anticancer drug resistance' 에 대한 통합검색결과 50건입니다.
한빛사50건
-
Antibiofilm and antifungal properties of SrWO4 microstructures against multi-azole-resistant Candida albicans and other microbes
- Chem. Eng. J. Available online 25 April 2025, 163091 | https://doi.org/10.1016/j.cej.2025.1630
- 2025.04
- 생명과학
-
G-protein coupled receptors in metabolic reprogramming and cancer
- Pharmacol. Ther. Available online 7 April 2025, 108849 | https://doi.org/10.1016/j.pharmthera.2025.108849
- 2025.04
- 의약학
-
SMYD family in cancer: epigenetic regulation and molecular mechanisms of cancer proliferation, metastasis, and drug resistance
- Exp. Mol. Med. 01 November 2024 | https://doi.org/10.1038/s12276-024-01326-8
- 2024.11
-
Manganese oxide nanomaterials: bridging synthesis and therapeutic innovations for cancer treatment
- Nano Converg. Nov 27 2024, 11 (1) 48 | https://doi.org/10.1186/s40580-024-00456-z
- 2024.11
- 생명과학
-
Emodin disrupts the KITENIN oncogenic complex by binding ErbB4 and suppresses colorectal cancer progression in dual blockade with KSRP-binding compoun
- Phytomedicine Available online 10 November 2024, 156247 | https://doi.org/10.1016/j.phymed.2024.156247
- 2024.11
- 의약학
-
Fibrosis-Encapsulated Tumoroid, A Solid Cancer Assembloid Model for Cancer Research and Drug Screening
- Adv. Healthc. Mater. Sep 05 2024, | https://doi.org/10.1002/adhm.202402391
- 2024.09
- 의약학
-
Enzyme-instructed intramitochondrial polymerization for enhanced anticancer treatment without the development of drug-resistance
- J. Control. Release Jul 16 2024, 373 S0168-3659(24)00459-0 | https://doi.org/10.1016/j.jconrel.2024.07.029
- 2024.07
- 바이오·의료융합
-
Tailoring polymeric nanocarriers for hypoxia-specific drug release: Insights into design and applications in clinics
- Chem. Eng. J. Available online 14 July 2024 | https://doi.org/10.1016/j.cej.2024.153978
- 2024.07
- 바이오·의료융합
-
Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation
- Exp. Mol. Med. Apr 16 2024, | https://doi.org/10.1038/s12276-024-01210-5
- 2024.04
- 의약학
-
Thermally annealed large-scale gold nanostructure platform for long-term and label-free electrochemical monitoring of cellular metabolism
- Chem. Eng. J. Available online 20 February 2024 | https://doi.org/10.1016/j.cej.2024.149864
- 2024.02
- 바이오·의료융합
-
Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
- Biomater. Res. Oct 16 2023, 27 (1) | https://doi.org/10.1186/s40824-023-00440-4
- 2023.10
- 바이오·의료융합
-
A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality
- Adv. Sci. 16 October 2023 | https://doi.org/10.1002/advs.202305096
- 2023.10
- 생명과학
-
Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective
- Exp. Mol. Med. Published: 03 July 2023 | https://doi.org/10.1038/s12276-023-01014-z
- 2023.07
- 생명과학
-
3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation
- Biofabrication 2023 Jun 6;15(3) | DOI 10.1088/1758-5090/acd95f
- 2023.06
- 바이오·의료융합
-
Overcoming multidrug-resistant lung cancer by mitochondrial-associated ATP inhibition using nanodrugs
- J. Nanobiotechnol. 12 January 2023, 21, Article number: 12 | https://doi.org/10.1186/s12951-023-01768-8
- 2023.01
- 의약학
-
Molecular targeted therapy for anticancer treatment
- Exp. Mol. Med. 2022 Oct;54(10):1670-1694 | https://doi.org/10.1038/s12276-022-00864-3
- 2022.10
- 생명과학
-
Blood-Lymphatic Integrated System with Heterogeneous Melanoma Spheroids via In-Bath Three-Dimensional Bioprinting for Modelling of Combinational Targe
- Adv. Sci. 2022 Oct;9(29):e2202093 | https://doi.org/10.1002/advs.202202093
- 2022.10
- 바이오·의료융합
-
TRAIL & EGFR affibody dual-display on a protein nanoparticle synergistically suppresses tumor growth
- J. Control. Release Volume 349, September 2022, Pages 367-378 | https://doi.org/10.1016/j.jconrel.2022.07.004
- 2022.09
- 생명과학
-
Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers
- J. Adv. Res. Available online 10 August 2022 | https://doi.org/10.1016/j.jare.2022.08.003
- 2022.08
- 의약학
-
CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells
- Theranostics 2022 Aug 8;12(13):5949-5970 | https://www.thno.org/v12p5949.htm
- 2022.08
- 생명과학
